Kairos Pharma, Ltd. (KAPA) earnings
KAPA earnings moved a median of +1.09% by the close. Quarterly and annual KAPA reports and results, each read against the price at its own news timestamp. Back to the KAPA overview →
11 measured KAPA earnings events.
Where these KAPA earnings landedvs 10 measured KAPA earnings reactions
| Middle 50% of KAPA earnings reactions | -3.83% to +2.88% |
|---|---|
| Median reaction (to close) | +1.09% |
| Measured reactions | 10 |
Point-in-time · zero look-ahead
Half of the 10 KAPA earnings events with a measured close landed between -3.83% and +2.88%; 60% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Kairos Pharma, LTD. For: Jun 30 | SEC filing · Form 10-Q | -4.06% | +1.52% | |
| Form 10-Q Kairos Pharma, LTD. For: Mar 31 | SEC filing · Form 10-Q | +1.91% | +4.52% | |
| Form 10-K Kairos Pharma, LTD. For: Dec 31 | SEC filing · Form 10-K | +1.07% | +4.84% | |
| Form 10-Q Kairos Pharma, LTD. For: Sep 30 | SEC filing · Form 10-Q | +2.28% | +3.34% | |
| Form 10-Q Kairos Pharma, LTD. For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-K/A Kairos Pharma, LTD. For: Dec 31 | SEC filing · Form 10-K | +0.90% | +0.95% | |
| Form 10-Q Kairos Pharma, LTD. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +1.24% | |
| Form 10-K/A Kairos Pharma, LTD. For: Dec 31 | SEC filing · Form 10-K | -2.75% | -6.20% | |
| Form 10-K Kairos Pharma, LTD. For: Dec 31 | SEC filing · Form 10-K | -5.79% | -12.75% | |
| Form NT 10-K Kairos Pharma, LTD. For: Dec 31 | SEC filing · Form NT | +0.00% | -3.48% | |
| Form 10-Q Kairos Pharma, LTD. For: Sep 30 | SEC filing · Form 10-Q | -0.05% | -3.95% |
Keep exploring
More KAPA: analyst actions → · SEC filings → · KAPA overview →